Heart failure study: can patients drink freely without harm?
NCT ID NCT07400991
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether people hospitalized for acute heart failure can safely drink as much as they want instead of limiting fluids. About 420 participants will be randomly assigned to either a strict 1.5 liters per day limit or a thirst-driven liberal intake. Researchers will measure how quickly patients stabilize, their thirst distress, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fluid intake strategy (behavioral intervention)
What this could lead to
If successful, this could show that letting heart failure patients drink as they wish is safe and may improve their comfort and quality of life.
What could go wrong
This is a moderate-sized trial testing a behavioral change, not a new drug. Results may not apply to all heart failure patients, and the liberal approach could worsen fluid overload in some cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Cardiology, Gødstrup Hospital
RECRUITINGHerning, 7400, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••